Title of Collaborative Activity: |
FDA Arthritis Drugs Advisory Committee Meeting |
Description of Collaborative Activity: |
An NIMH Program Officer was invited to serve as a voting ad hoc member of one of the FDA's standing advisory committees, which met to review a new drug application for the treatment of Chronic Fatigue Syndrome. |
Type of Collaborative Activity: |
Select Type of Collaborative Activity
|
Year the Collaborative Activity Originated: |
2012 |
NIH Participating Institutes/Centers/Office of the Director: |
NIMH |
HHS Agency Collaborators on this Activity: |
CDC, FDA |